Dernière mise à jour: Août 17, 2026

Une société de recherche clinique de Toronto teste les États-Unis. expansion

 

Toronto-based clinical research firm BioPharma Services Inc. affirme que sa nouvelle clinique dans le Missouri l'aide à répondre à la demande croissante des États-Unis. fabricants de produits pharmaceutiques.

L’installation de développement clinique de phase précoce de la société, situé en Colombie, Missouri, a actuellement 48 beds and has plans to expand to 140 beds.

La clinique, which has been operating since last November, has completed three studies and expects to conduct another four to six by the end of the year, Renzo DiCarlo, chief executive officer of BioPharma Services, said in an interview.

“There happens to be a shortage of clinical research companies in the U.S. right now for this type of work. We wanted to go quickly to fill that unmet need for our clients,” DiCarlo said. “It seems to be working quite well.”

The ribbon cutting for the Columbia site, slated to take place on Wednesday, will include Missouri Governor Jay Nixon, Columbia Mayor Bob McDavid, and executives from leading pharmaceutical companies, BioPharma said in a release.

BioPharma is based in North York, near Weston Road and Steeles Avenue West, where it has a 174-bed clinic that specializes in what are known as first in human laboratory trials, as well as generic and bioanalytical testing. The facility meets government inspection standards for the U.S., U.K. and Canada.

One of the pharmaceuticals it is currently testing is an anti-coagulant, DiCarlo said. Demand for blood thinners is on the rise because of the risk of blood clots that comes with the growing use of knee replacements.

“The odds of having a blood clot are quite high because of the extent of the surgery,” DiCarlo said. “Getting a better product out on the market which prevents blood clots is a significant improvement to the health and well-being of the public.”

 

À propos 40 per cent of BioPharma’s clients are U.S. drug makers, another 40 per cent are based in Europe and the remaining portion are Asian companies, DiCarlo said. “We do clinical trials and lab testing for clients regardless of geography and jurisdiction.”

BioPharma Services was founded by a group of doctors and medical professionals in 2006. The privately held firm is still owned and operated by physicians, DiCarlo said. It has annual revenues of about $30 million.

“We are very proud of what we’re doing and that we’re expanding outside of Canada,” DiCarlo said. “We are a Canadian company that’s growing.”

MORE AT THESTAR.COM

Revue de cas scientifique

Examen de cas scientifiques

Souhaitez-vous savoir si les programmes cliniques actuels, développements récents en recherche, ou des approches émergentes peuvent être adapté à votre situation individuelle?

Partagez votre question avec notre équipe de recherche scientifique et recevez informations axées sur les domaines de recherche en cours qui peuvent être pertinent pour votre cas.

  • Examen des informations que vous fournissez
  • Informations pertinentes sur la recherche et les programmes cliniques
  • Une réponse claire et adaptée à votre situation
Que se passe-t-il ensuite? Envoyez votre question, recevoir une évaluation scientifique ciblée, et obtenez une réponse claire sur les programmes de recherche et cliniques pertinents à votre situation.
Votre revue scientifique sera préparée par Docteur. Hélène Melnik, Doctorat , qui a plus de 25 années d'expérience dans la recherche sur les cellules souches et les programmes cliniques internationaux.

Aucune obligation. Votre question sera examinée de manière confidentielle.

Informations pédagogiques et de recherche uniquement. Ce service ne constituer un avis médical, diagnostic, ordonnance, ou un personnalisé recommandation de traitement.


NBScience

organisme de recherche sous contrat

WhatsApp